Search | Search by Center | Search by Source | Keywords in Title
VA Pharmacy Benefits Management Services, Medical Advisory Panel, and VISN Pharmacist Executives with, Gordon AJ, Kivlahan D, Liberto J, McNicholas L, Oslin DW, Saxon A, Trafton J. Buprenorphine / Naloxone and Buprenorphine Sublingual Formulations for Opioid Dependence. Criteria for Use for Office-Based Opioid Treatment (OBOT) Settings. 2013 Apr 1.
Buprenorphine Sublingual Criteria. www.pbm.va.gov/clinicalguidance/criteriaforuse/BuprenorphineSublingualCriteriaforUse.pdf (Washington, DC: US Department of Veterans Affairs)